According to the announcement of Magic Pharmaceuticals, from January to September 2026, it achieved main business revenue of 1,249 billion yuan, a year-on-year decrease of 10.62%; the gross profit margin of the main business was 44.37%, a year-on-year decrease of 2.69 percentage points. By industry, pharmaceutical manufacturing revenue was 675 million yuan, down 17.05% year on year; pharmaceutical commercial revenue was 574 million yuan, down 1.64% year on year. By region, export revenue increased 147.41% year over year, while Southwest China and South China increased by 3.75% and 1.16% respectively. Revenue declined to varying degrees in the rest of the regions.
Zhitongcaijing · 3d ago
Share
Listen to the news
According to the announcement of Magic Pharmaceuticals, from January to September 2026, it achieved main business revenue of 1,249 billion yuan, a year-on-year decrease of 10.62%; the gross profit margin of the main business was 44.37%, a year-on-year decrease of 2.69 percentage points. By industry, pharmaceutical manufacturing revenue was 675 million yuan, down 17.05% year on year; pharmaceutical commercial revenue was 574 million yuan, down 1.64% year on year. By region, export revenue increased 147.41% year over year, while Southwest China and South China increased by 3.75% and 1.16% respectively. Revenue declined to varying degrees in the rest of the regions.
Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending